

GN Store Nord A/S (GNNDY) Q2 2026 Earnings Call Transcript

GN Store Nord (OTCMKTS:GNNDY - Get Free Report) and Resonate Blends (OTCMKTS:KOAN - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, institutional ownership and risk. Volatility and Risk GN Store Nord has

GN Store Nord (OTCMKTS:GNNDY - Get Free Report) was the target of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 277 shares, a decrease of 79.6% from the July 15th total of 1,359 shares. Based on an average daily trading volume, of 400

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them.

GN Store Nord A/S (GNNDY) Q1 2026 Earnings Call Transcript

Baxter International (NYSE: BAX - Get Free Report) and GN Store Nord (OTCMKTS:GNNDY - Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, dividends, earnings and analyst recommendations. Risk and Volatility Baxter International has

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them.

GN Store Nord (OTCMKTS:GNNDY - Get Free Report)'s share price rose 6.5% on Friday. The stock traded as high as $45.18 and last traded at $45.05. Approximately 815 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 590 shares. The stock had previously closed at $42.30. Analyst
No recent filings indexed.